Notably, current evidence indicates a reduction in aryl hydrocarbon receptor (AhR) expression within the intestinal tissue of IBD patients; at the same time, the mucosal barrier is restored in mouse models of intestinal inflammation through AhR signaling via IL-22 [6]. Here, AHR is linked to inflammatory bowel disease.